登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C7H5NO5 · xH2O
化学文摘社编号:
分子量:
183.12 (anhydrous basis)
UNSPSC Code:
12352202
NACRES:
NA.77
PubChem Substance ID:
EC Number:
205-335-8
Beilstein/REAXYS Number:
476229
MDL number:
产品名称
白屈氨酸 水合物, ≥95%, powder
InChI key
SNGPHFVJWBKEDG-UHFFFAOYSA-N
InChI
1S/C7H5NO5.H2O/c9-3-1-4(6(10)11)8-5(2-3)7(12)13;/h1-2H,(H,8,9)(H,10,11)(H,12,13);1H2
SMILES string
O.OC(=O)C1=CC(=O)C=C(N1)C(O)=O
biological source
synthetic (organic)
assay
≥95%
form
powder
color
brown
mp
267 °C (dec.) (lit.)
solubility
1 M NH4OH: 50 mg/mL, clear to slightly hazy
Quality Level
正在寻找类似产品? 访问 产品对比指南
相关类别
Application
白屈氨酸水合物已用于洗脱液,作为高效螯合离子色谱(HPCIC)中的络合添加剂进行铁形态分析。它还用作多金属氧酸盐(POM)基镧系杂化化合物的有机配体。
Biochem/physiol Actions
其属于最有效的“构象受限的谷氨酸类似物”,是谷氨酸脱羧酶抑制剂。
白屈氨酸(CDA)是2,6-吡啶二羧酸(DPA)的羟基化衍生物,是一种三阴离子螯合剂。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Maryam Samaniyan et al.
Dalton transactions (Cambridge, England : 2003), 50(5), 1895-1900 (2021-01-22)
A novel inorganic-organic hybrid, {Na[Tb(L)(H2O)4]3(SiW12O40)}·4H2O, in which L = 4-hydroxypyridine-2,6-dicarboxylic acid (chelidamic acid), was prepared and characterized by elemental analyses, Fourier transform infrared spectroscopy, and single-crystal X-ray diffraction. It consists of a trinuclear terbium cluster bonded to a Keggin-type polyoxotungstate.
Chelidamic acid as a new eluent for the determination of Fe (II) and Fe (III) species and other metals by high performance chelation ion chromatography
Dias J, et al.
Chromatographia null
Construction of a dinuclear cluster containing La (?) and 4-hydroxypyridine-2, 6-dicarboxylic acid to modify Keggin-type polyoxometalate
Taghipour F and Mirzaei M
Journal of Molecular Structure null
Chelidamic acid monohydrate: the proton complex of a multidentate ligand
Hall et al.
Acta crystallographica. Section C, Crystal structure communications, 56 (Pt 4), 448-450 (2000-05-18)
M Searcey et al.
Anti-cancer drug design, 13(8), 837-855 (1999-05-21)
We have explored the potential antitumour activity of DNA-intercalating free radical generators based on compounds constructed from 9-anilinoacridine and chelidamic acid as an iron (II) binding centre. Here we describe their synthesis, DNA cleaving ability and activity against a panel
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持